Table 4.
Variables | β | SE | Wald | P | HR | 95.0% for CI |
---|---|---|---|---|---|---|
Gender | -0.113 | 0.366 | 0.093 | 0.761 | 0.893 | 0.432-1.846 |
Tumor stage | 2.914 | 0.943 | 20.521 | <0.001 | 18.428 | 5.223-65.012 |
Lymph node metastasis | 1.118 | 0.862 | 7.099 | 0.008 | 2.769 | 1.309-5.856 |
Bismuth-Coretre type | 0.698 | 0.677 | 0.525 | 0.509 | 1.384 | 0.538-2.762 |
Neural invasion | 0.811 | 0.735 | 0.725 | 0.355 | 2.057 | 1.098-5.042 |
Portal vein invasion | 0.437 | 0.440 | 0.016 | 0.700 | 1.070 | 0.371-3.083 |
Total bilirubin | 0.682 | 0.661 | 0.436 | 0.636 | 1.219 | 0.423-5.656 |
CA19-9 | 1.184 | 0.880 | 7.728 | 0.005 | 2.957 | 1.377-6.350 |
NLR | 0.546 | 0.535 | 0.307 | 0.687 | 1.147 | 0.455-4.404 |
LMR | -1.708 | 0.889 | 19.271 | <0.001 | 0.181 | 0.085-0.389 |
LMR, lymphocyte monocyte ratio; HR, hazard ratio; CI, confidence interval.